These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

776 related items for PubMed ID: 17681707

  • 1. A novel approach to HIV therapy: highly active antiretroviral therapy and autologous hematopoietic cell transplantation.
    Pippi F.
    Med Hypotheses; 2008; 70(2):291-3. PubMed ID: 17681707
    [Abstract] [Full Text] [Related]

  • 2. High dose therapy and autologous stem cell transplantation for human immunodeficiency virus-associated non-Hodgkin lymphoma in the era of highly active antiretroviral therapy.
    Molina A, Krishnan AY, Nademanee A, Zabner R, Sniecinski I, Zaia J, Forman SJ.
    Cancer; 2000 Aug 01; 89(3):680-9. PubMed ID: 10931469
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. High-dose therapy plus autologous hematopoietic stem cell transplantation for human immunodeficiency virus (HIV)-related lymphoma: results and impact on HIV disease.
    Gabarre J, Marcelin AG, Azar N, Choquet S, Lévy V, Lévy Y, Tubiana R, Charlotte F, Norol F, Calvez V, Spina M, Vernant JP, Autran B, Leblond V.
    Haematologica; 2004 Sep 01; 89(9):1100-8. PubMed ID: 15377471
    [Abstract] [Full Text] [Related]

  • 5. Failure to reconstitute CD4+ T-cells despite suppression of HIV replication under HAART.
    Aiuti F, Mezzaroma I.
    AIDS Rev; 2006 Sep 01; 8(2):88-97. PubMed ID: 16848276
    [Abstract] [Full Text] [Related]

  • 6. Reservoirs of human immunodeficiency virus type 1: the main obstacles to viral eradication.
    Pomerantz RJ.
    Clin Infect Dis; 2002 Jan 01; 34(1):91-7. PubMed ID: 11731950
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. HIV-1 viral replication below 50 copies/ml in patients on antiretroviral therapy is not associated with CD8+ T-cell activation.
    Steel A, Cox AE, Shamji MH, John L, Nelson M, Henderson DC, Gotch FM, Gazzard BG, Kelleher P.
    Antivir Ther; 2007 Jan 01; 12(6):971-5. PubMed ID: 17926652
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Immunogenicity and effect of a virosomal influenza vaccine on viral replication and T-cell activation in HIV-infected children receiving highly active antiretroviral therapy.
    Tanzi E, Esposito S, Bojanin J, Amendola A, Trabattoni D, Pariani E, Pinzani R, Zanetti A, Principi N.
    J Med Virol; 2006 Apr 01; 78(4):440-5. PubMed ID: 16482542
    [Abstract] [Full Text] [Related]

  • 11. Intensification and stimulation therapy for human immunodeficiency virus type 1 reservoirs in infected persons receiving virally suppressive highly active antiretroviral therapy.
    Kulkosky J, Nunnari G, Otero M, Calarota S, Dornadula G, Zhang H, Malin A, Sullivan J, Xu Y, DeSimone J, Babinchak T, Stern J, Cavert W, Haase A, Pomerantz RJ.
    J Infect Dis; 2002 Nov 15; 186(10):1403-11. PubMed ID: 12404155
    [Abstract] [Full Text] [Related]

  • 12. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A, Leti W, De Santis W, Marziali M, Esposito A, Fimiani C, Luzi G, Pinti M, Cossarizza A, Aiuti F, Mezzaroma I.
    Clin Infect Dis; 2008 Jun 15; 46(12):1902-10. PubMed ID: 18462177
    [Abstract] [Full Text] [Related]

  • 13. Dynamics of the pool of infected resting CD4 HLA-DR- T lymphocytes in patients who started a triple class five-drug antiretroviral regimen during primary HIV-1 infection.
    Sankatsing SU, van Praag RM, van Rij RP, Rientsma R, Jurriaans S, Lange JM, Prins JM, Schuitemaker H.
    Antivir Ther; 2003 Apr 15; 8(2):137-42. PubMed ID: 12741626
    [Abstract] [Full Text] [Related]

  • 14. HIV-1 viral rebound dynamics after a single treatment interruption depends on time of initiation of highly active antiretroviral therapy.
    Steingrover R, Pogány K, Fernandez Garcia E, Jurriaans S, Brinkman K, Schuitemaker H, Miedema F, Lange JM, Prins JM.
    AIDS; 2008 Aug 20; 22(13):1583-8. PubMed ID: 18670217
    [Abstract] [Full Text] [Related]

  • 15. Mathematical modelling of the impact of haematopoietic stem cell-delivered gene therapy for HIV.
    Murray JM, Fanning GC, Macpherson JL, Evans LA, Pond SM, Symonds GP.
    J Gene Med; 2009 Dec 20; 11(12):1077-86. PubMed ID: 19777528
    [Abstract] [Full Text] [Related]

  • 16. HIV-1 dynamics after transient antiretroviral therapy: implications for pathogenesis and clinical management.
    Phillips AN, McLean A, Johnson MA, Tyrer M, Emery V, Griffiths P, Bofill M, Janossy G, Loveday C.
    J Med Virol; 1997 Nov 20; 53(3):261-5. PubMed ID: 9365893
    [Abstract] [Full Text] [Related]

  • 17. High-dose therapy and autologous stem cell transplantation for children with HIV-associated non-Hodgkin lymphoma.
    Fluri S, Ammann R, Lüthy AR, Hirt A, Aebi C, Duppenthaler A, Leibundgut K.
    Pediatr Blood Cancer; 2007 Dec 20; 49(7):984-7. PubMed ID: 16685736
    [Abstract] [Full Text] [Related]

  • 18. Stem cell transplantation for lymphoma patients with HIV infection.
    Michieli M, Mazzucato M, Tirelli U, De Paoli P.
    Cell Transplant; 2011 Dec 20; 20(3):351-70. PubMed ID: 20875226
    [Abstract] [Full Text] [Related]

  • 19. Suppression of viral replication with highly active antiretroviral therapy has no impact on the functional profile of HIV-specific CD8(+) T cells.
    López M, Soriano V, Rallón N, Cascajero A, González-Lahoz J, Benito JM.
    Eur J Immunol; 2008 Jun 20; 38(6):1548-58. PubMed ID: 18421792
    [Abstract] [Full Text] [Related]

  • 20. Opportunistic infection as a cause of transient viremia in chronically infected HIV patients under treatment with HAART.
    Jones LE, Perelson AS.
    Bull Math Biol; 2005 Nov 20; 67(6):1227-51. PubMed ID: 16023709
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 39.